It has been recently demonstrated that evaluation of serum VEGF, PlGF, and sFlt-1 levels can differentiate between preeclampsia, inactive SLE, and active LN during pregnancy [39]. This evidence concerns the gene VEGFA and systemic lupus erythematosus.